S.73 - End Taxpayer Subsidies for Drug Ads Act116th Congress (2019-2020) |
|Sponsor:||Sen. Shaheen, Jeanne [D-NH] (Introduced 01/10/2019)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 01/10/2019 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.73 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (01/10/2019)
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.